Introduction
The obesity and metabolic syndrome related to it constitute one of the biggest health threats of the 21st century. For many centuries, researchers have been searching for the reason for this issue and, fi rst of all, for effective treatment methods. However, it was noticed in the 1980s that excessive body mass cannot be a basis for the development of all troubles related to metabolic syndrome. A concept of a metabolically obese normal weight (MONW) was created. This occurs among people with an appropriate Body Mass Index (BMI) value and is typifi ed by a combination of metabolism disorders characteristic for obese people with metabolic syndrome. Taking into consideration the fact that in the population of "healthy people", the percentage of the total number of MONW subjects may concern even up to 30%, some efforts were undertaken in order to identify this disease [1] .
The fi rst criteria for identifi cation of metabolic syndrome among non-obese people was proposed in 1998 by Rudermann et al. [1] . A system composed of 22 traits was created on the basis of the analysis of earlier research. Each of them was marked with a numerical value ( Table 1) . The Metabolically Obese Normal-Weight (MONW) was supposed to be recognised when the sum of those values reached 7 points. This system seems to be easy to use in everyday practice, although it requires the use of the results of biochemical tests that are rarely conducted among non-obese people [2] .
Further criteria of the MONW diagnosis were based on the indices of carbohydrate metabolism disorders and insulin resistance, adipose tissue content in the organism and also with the use of the criteria of metabolic syndrome ( Table 2) .
Carbohydrate metabolism and insulin resistance
The problem of MONW's characteristics was elaborated by Dvorak's team. He defi ned MONW on the basis of a BMI below 26.3 kg/m with co-existing insulin resistance (determined by means of the euglycemic clamp technique). The glucose utilisation at a level of 8 mg/min/kg of the Fat Free Mass (FFM) was adopted as the boundary value [3] . A disadvantage of this method is a necessity of carrying out the euglycemic clamp technique examination, which is technically diffi cult and labour intensive, thereby unsuitable as a tool to be applied in everyday practice [4] [7] . It is quite strict criterion because in customary assessment, insulin resistance is recognised only at the value of 2.5. The authors considered though that among people with a normal body mass, we can observe a clinically significant reduction of the tissue's sensitivity to insulin already in the case of much lower values [4] . It is also worth mentioning a proposal of Succurro et al. who, just like his predecessors, assessed the BMI, although they introduced a new index -M FFM -indicating an average glucose infusion rate within the last 60 minutes of the examination Fat mass content
Other diagnostic criteria were proposed by Katsuki et al. who initiated a view on the non-obese patients through the Fat Mass (FM) content in the organism. As their predecessors did, they adopted a BMI below 25 kg/m 2 as the indicative parameters, but they took into consideration the abdominal FM determined by means of computed tomography. The deposit of abdominal FM above 100 cm 2 was adopted as the boundary value [9] [10] [11] . However, the execution of computed tomography entails high costs and the exposure Madeira et al. were assessing the thickness of a fold above the scapula and triceps muscle, recognising those people among whom the sum of these values was above the 90th percentile as the NWO persons. Alternatively, they were assessing the percentage of FM in the organism, applying the limit of 30% for women and 23% for men [18] .
Metabolic syndrome criteria Identical criteria were adopted in this year's research by Galić et al. [23] .
Other parameters
In the literature in the area of the diagnosis of metabolic syndrome with normal body weight, we can also fi nd proposals of the use of other indexes -including biochemical. Among others, an additional correlation between the occurrence of MONW and ferritin concentration in blood serum over 127.03 ng/ml for women and 46.87 ng/ml for men was stated [24] . A positive correlation is observed also with the TyG index value (concentration of triglycerides x fasting glucose/2) over 8.73 for women and 8.82 for men [25] . These parameters may be used to an early MONW recognition in the future.
Conclusion
It results from the short overview concerning the criteria of the diagnosis of MONW that the constant diagnostic element adopted by all the authors is the Body Mass Index (BMI). However, there is no common agreement on the boundary value for increased body mass (range from 23 to 27 kg/m 2 ). In terms of assessment of metabolism disorders, the majority of researchers draw attention to carbohydrate metabolism or insulin resistance recognised on the basis of various criteria. The others considered the content and distribution of fat tissue in the body as the basis for the MONW recognition [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] . The researchers centred around Rudermann consider metabolism disorders, i.e. higher triglyceride content, reduced HDL cholesterol level, higher blood pressure [2, 15, 20, 22, 23] and generalised inflammation [15] as crucial. It is worth noting that the fi rst criteria ( Table 1 ) also took into consideration a higher uric acid concentration, body mass gain as an adult, predisposing medical history and family factors, while the most recent studies suggest a correlation between the occurrence of MONW and the ferritin level and TyG index [24, 25] . To sum up, despite a great deal of research conducted so far, it seems necessary to set up a group of experts in order to prepare uniform guidelines that will be applicable in everyday clinical practice.
